Back to Journals » ClinicoEconomics and Outcomes Research » Volume 3

The costs of hospitalization in patients with acute exacerbation of chronic obstructive pulmonary disease

Authors Ozkaya, Findik S, Gatici A

Published 17 January 2011 Volume 2011:3 Pages 15—18

DOI https://doi.org/10.2147/CEOR.S14820

Review by Single-blind

Peer reviewer comments 2


Sevket Ozkaya1, Serhat Findik2, Atilla Guven Atici2
1Rize University, Department of Pulmonary Medicine, Rize, Turkey; 2Ondokuz Mayis University, Department of Pulmonary Medicine, Atakum, Samsun, Turkey

Introduction: Chronic obstructive pulmonary disease (COPD) is a major public health problem. It imparts a substantial economic burden on individuals and society. Acute exacerbations are the main cause of hospital admissions and hospitalizations in patients with COPD in Turkey.
Objectives: We aimed to determine the costs of hospitalization in patients with acute exacerbations of COPD (AECOPD).
Results: A total of 7832 (1556 women, 6276 men) patients were hospitalized due to acute exacerbations of COPD between 2005–2009 in the Samsun Chest Diseases and Thoracic Surgery Hospital, northern Turkey. The mean age was 64.6 ± 19.8 years old and median length of hospital stay was 14.8 ± 9.5 days. The mean cost per admission was US$718 ± 364. Drug costs accounted for the largest portion (53.5%) of the mean cost, followed by bed cost (19.6%). One hundred seventy-four (2.2%) of the total hospitalized patients with AECOPD died in hospital.
Conclusion: AECOPD continues to have both significant economic burden and high mortality rate.

Keywords: COPD, acute exacerbation, hospitalization, costs

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]